Advertisement

Inhibitory Effects of Roquefortine on Hepatic Cytochromes P450

  • C. Aninat
  • M. Delaforge
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 500)

Abstract

Roquefortine, a cyclodipeptide derived from the diketopiperazine cyclo (TrpdehydroHis), is a secondary metabolite produced by some Penicillium species (1,2). P. roqueforti is considered as one of the most important fungal contaminants of carbonated beverages, beer, wine, meats, cheese, bread. It is reported to be among the predominant species in silage.

Keywords

Liver Microsome Difference Spectrum Indole Alkaloid Penicillium Species Carbonate Beverage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    Ohmono S, Sato T, Utagawa T, Abe M. Isolation of festuclavine and three new indole alkaloids, roquefortine A, B and C from the cultures of Penicillium roqueforti (production of alkaloids and related substances by fungi part XII). Agric. Chem. Soc. Japan. 1975; 49: 615–623.Google Scholar
  2. (2).
    Reshetilova TA, Kozlovsky AG. Synthesis and metabolism of roquefortine in Penicillium species. J Basic Microbiol. 1990; 30: 109–114.PubMedCrossRefGoogle Scholar
  3. (3).
    Arnold DL, Scott PM, McGuire PF, Harwig J, Nera EA. Acute toxicity studies on roquefortine and PR toxin, metabolites of Penicillium roqueforti in the mouse. Fd. Cosmet. Tozicol. 1978; 16: 369–371.CrossRefGoogle Scholar
  4. (4).
    Kopp-Holtwiesche B, Rehm HJ. Anitimicrobial action of roquefortine. J. Enrion. Pathol. Tozicol. Oncol. 1990; 10: 41–44.Google Scholar
  5. (5).
    Peyronneau MA, Delaforge M, Rivière R, Renaud JP, Mansuy D. High affinity of ergopeptides for cytochromes P4503A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine. Eur.J.Biochem. 1994; 223: 947–956.PubMedCrossRefGoogle Scholar
  6. (6).
    Peyronneau MA, Renaud JP, Truan G, Urban P, Pompon D, Mansuy D. Optimization of yeast-expressed human liver cytochrome-P450 3A4 catalytic activities by coexpressing NADPH-cytochrome-P450-reductase and cytochrome-b5. Eur. J. Biochem. 1992; 207: 109–116.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • C. Aninat
    • 1
  • M. Delaforge
    • 1
  1. 1.CEA Saclay, Département de la Recherche MédicaleService de Pharmacologie et d’ImmunologieFrance

Personalised recommendations